Sophiris Bio Inc EV/EBIT
What is the EV/EBIT of Sophiris Bio Inc?
The EV/EBIT of Sophiris Bio Inc is 27.44
What is the definition of EV/EBIT?
Enterprise value to earnings before interest and taxes (EV/EBIT) is a financial ratio used to measure if a stock is priced appropriately to similar stocks and the market. It is similar to the P/E ratio.
ttm (trailing twelve months)
The EV/EBIT ratio addresses some of the shortcomings of the P/E ratio. Instead of taking market capitalization, the ratio uses enterprise value, as it takes into account the true value of the company. Enterprise value includes both equity and debt. It is calculated as:
Enterprise value = market cap + total debt – cash and cash equivalents
The EV/EBIT ratio is useful in comparing peers within the wider market. A high EV/EBIT ratio indicates that a company’s stock is overvalued. On the opposite, a low EV/EBIT ratio indicates that a company’s stock is undervalued. The lower the ratio, the more financially stable a company should be. However, investors and analyst should use other ratios and information to get a full picture of a company’s financial state and actual value.
EV/EBIT of companies in the Health Care sector on NASDAQ compared to Sophiris Bio Inc
Companies with ev/ebit similar to Sophiris Bio Inc
- Maxar Technologies has EV/EBIT of 27.36
- i3 Verticals Inc has EV/EBIT of 27.38
- Dow Inc has EV/EBIT of 27.38
- General Electric has EV/EBIT of 27.39
- Global X Funds has EV/EBIT of 27.40
- UV Germi SA has EV/EBIT of 27.41
- Sophiris Bio Inc has EV/EBIT of 27.44
- Fine Organic Industries has EV/EBIT of 27.45
- Apollo Pipes has EV/EBIT of 27.46
- CoreCard has EV/EBIT of 27.46
- Firm Capital Apartment Real Estate Investment Trust has EV/EBIT of 27.46
- STL Global has EV/EBIT of 27.47
- Fidelity D&D has EV/EBIT of 27.48